Canopy Growth (WEED) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
20 Jan, 2026Opening remarks and agenda
Meeting held virtually with introductions of board members and key executives, including CEO, CFO, and legal counsel.
Independent auditor and scrutineer introduced; meeting agenda and rules of conduct referenced.
Four formal business items outlined: financial statements, director elections, auditor reappointment, and Say-on-Pay proposal.
Board and executive committee updates
Board nominees for election included current chair, CEO, and three other directors, with biographies available in the proxy.
Financial performance review
Audited consolidated financial statements for fiscal years ending March 31, 2024 and 2023 presented, available for shareholder review.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Canopy Growth
- Q3 FY2026 saw stable revenue, improved margins, and strategic moves to lead in cannabis markets.WEED
Investor presentation23 Mar 2026 - Registering 18.7M shares for resale, with proceeds from warrants supporting investments amid financial risk.WEEDRegistration Filing6 Feb 2026
- Net loss narrowed 49% as Canadian cannabis grew and cost savings improved EBITDA.WEEDQ3 20266 Feb 2026
- Gross margin up 35%, EBITDA loss narrowed 77%, medical and international growth strong.WEEDQ1 20251 Feb 2026
- Gross margin rose to 35% as Storz & Bickel and medical cannabis drove improved profitability.WEEDQ2 202515 Jan 2026
- 52.3 million shares registered for resale amid financial uncertainty and high risk.WEEDRegistration Filing9 Jan 2026
- Medical cannabis and Storz & Bickel growth drove improved margins and reduced losses.WEEDQ3 202523 Dec 2025
- Shareholders will vote on directors, auditor, share consolidation, and executive pay, with all recommended for approval.WEEDProxy Filing2 Dec 2025
- Proxy outlines virtual AGM, cost cuts, governance updates, and key votes on directors and pay.WEEDProxy Filing2 Dec 2025